Back to search
Endogenous Cushing Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Endogenous Cushing Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Endogenous Cushing Syndrome trials you may qualify forThe major goal of this study is to determine the incidence of adrenal insufficiency in patients with endogenous Cushing syndrome receiving osilodrostat treatmen…
The main hypothesis of the HEPACORT study is that upon diagnosis of endogenous Cushing's syndrome, significant liver fibrosis may be present, particularly in th…
This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully completed p…
This is a non-interventional study to assess the prevalence of endogenous hypercortisolism (eHC) in patients with resistant hypertension (rHTN) and will enroll…
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat admini…